NCT04120493: Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 43 planned
- Started
- 6 Sep 2019
- Primary completion
- Jun 2029
- Arms
- Cohort 1, Cohort 2, Cohort 3, Cohort 4
- Results
- None posted
- 6 Sep 2019: Trial started
- 9 Oct 2019: Trial registered